Michael Sizemore
Psychiatric/Mental Health · Richmond, INNPI 1184335762
Payments from drug & device makers
Across 259 payments — averaging $14.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$529
- Neurocrine Biosciences, Inc.$504
- Otsuka America Pharmaceutical, Inc.$323
- Vanda Pharmaceuticals Inc.$265
- Axsome Therapeutics, Inc.$222
- plus $1K from 16 others
What the payments were for
- Food & beverage$3,80298%
- Education$712%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 77 | $1,030 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 35 | $529 |
| Neurocrine Biosciences, Inc. | 41 | $504 |
| Otsuka America Pharmaceutical, Inc. | 21 | $323 |
| Vanda Pharmaceuticals Inc. | 19 | $265 |
| Axsome Therapeutics, Inc. | 11 | $222 |
| Teva Pharmaceuticals USA, Inc. | 11 | $217 |
| Alkermes, Inc. | 11 | $193 |
| Johnson & Johnson | 8 | $182 |
| Lundbeck LLC | 8 | $129 |
| Luye Pharma (USA) Ltd. | 3 | $57 |
| Novo Nordisk | 2 | $35 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Boston Scientific | 1 | $21 |
| Indivior Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Watermark Medical, Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
| Corium, LLC | 1 | $12 |
How this compares
$3,874 in reported general payments places this provider in the 85th percentile of 729 psychiatric/mental health providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 37 | $284,447 |
| Invega SustennaPaliperidone Palmitate | 34 | $108,663 |
| VraylarCariprazine Hcl | 26 | $36,575 |
| RexultiBrexpiprazole | 23 | $34,045 |
| Paliperidone ErPaliperidone | 33 | $13,139 |
| TrintellixVortioxetine Hydrobromide | 20 | $12,061 |
| Lamotrigine ErLamotrigine | 27 | $3,603 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 41 | $3,439 |
| Ziprasidone Hcl | 25 | $2,324 |
| Divalproex Sodium | 58 | $2,176 |
| Hydroxyzine Hcl | 95 | $1,931 |
| Vilazodone Hcl | 14 | $1,642 |
| Atomoxetine Hcl | 12 | $1,337 |
| Quetiapine Fumarate | 134 | $1,133 |
| Buspirone Hcl | 130 | $1,041 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $504 | $284,44737 claims |
| Johnson & JohnsonInvega Sustenna | $182 | $108,66334 claims |
| AbbVieVraylar | $1,030 | $36,57526 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $323 | $34,04523 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $29 | $12,06120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 729 psychiatric/mental health providers in Indiana.
Other psychiatric/mental health in Richmond
- Courtney FullmerRichmond$6K
- Brooke KempfTerre Haute$1.1M
- Gerald LewisMerrillville$336K
- Lauren LutzColumbus$320K
- Sonya RuedlingerIndianapolis$134K
- Trina GreenwaldMarion$107K
- Paul DuncanJeffersonville$46K
- Morgan StamperConnersville$42K
- Jennifer JimenezUnion Mills$37K
- Savannah MullinsClarksville$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.